Clinical Trials
15 trialsNCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT03647592 2023-12-27
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Unknown
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
NCT04788381 2021-03-09
The Effects of Preoperative Bevacizumab on Perioperative Complications
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT02745691 2019-12-13
Psychometric Properties of the EORTC QLQ-LC29
University Hospital Regensburg
Completed
NCT02093000 2018-02-23
A Study Examining Maintenance Bevacizumab (AvastinĀ®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Hoffmann-La Roche
Completed
NCT03195569 2017-06-22
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and AvastinĀ® in Patients With Non-squamous Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.
Unknown
NCT03170284 2017-05-31
AVALANCHE
Hoffmann-La Roche
Completed
NCT00898417 2017-05-19
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Eastern Cooperative Oncology Group
Completed
NCT00900172 2017-05-19
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Eastern Cooperative Oncology Group
Completed
NCT02596958 2016-04-04
Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
Hoffmann-La Roche
Completed
NCT01507740 2015-04-29
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Medical University Innsbruck
Terminated
NCT01891708 2013-07-03
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
Huazhong University of Science and Technology
Unknown
NCT01814163 2013-03-19
ANGIOMET
Spanish Lung Cancer Group
Completed